» Articles » PMID: 28621425

Epigenetic Mechanism of FMR1 Inactivation in Fragile X Syndrome

Overview
Journal Int J Dev Biol
Date 2017 Jun 17
PMID 28621425
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Fragile X syndrome is the most frequent cause of inherited intellectual disability. The primary molecular defect in this disease is the expansion of a CGG repeat in the 5' region of the fragile X mental retardation1 (FMR1) gene, leading to de novo methylation of the promoter and inactivation of this otherwise normal gene, but little is known about how these epigenetic changes occur during development. In order to gain insight into the nature of this process, we have used cell fusion technology to recapitulate the events that occur during early embryogenesis. These experiments suggest that the naturally occurring Fragile XFMR1 5' region undergoes inactivation post implantation in a Dicer/Ago-dependent targeted process which involves local SUV39H-mediated tri-methylation of histone H3K9. It thus appears that Fragile X syndrome may come about through inadvertent siRNA-mediated heterochromatinization.

Citing Articles

Epigenetic insights into Fragile X Syndrome.

Xie L, Li H, Xiao M, Chen N, Zang X, Liu Y Front Cell Dev Biol. 2024; 12:1432444.

PMID: 39220684 PMC: 11362040. DOI: 10.3389/fcell.2024.1432444.


Directly reprogrammed fragile X syndrome dorsal forebrain precursor cells generate cortical neurons exhibiting impaired neuronal maturation.

Edwards N, Combrinck C, McCaughey-Chapman A, Connor B Front Cell Neurosci. 2023; 17:1254412.

PMID: 37810261 PMC: 10552551. DOI: 10.3389/fncel.2023.1254412.


Towards Kinase Inhibitor Therapies for Fragile X Syndrome: Tweaking Twists in the Autism Spectrum Kinase Signaling Network.

DIncal C, Broos J, Torfs T, Kooy R, Vanden Berghe W Cells. 2022; 11(8).

PMID: 35456004 PMC: 9029738. DOI: 10.3390/cells11081325.


(Dys)function Follows Form: Nucleic Acid Structure, Repeat Expansion, and Disease Pathology in Disorders.

Zhao X, Usdin K Int J Mol Sci. 2021; 22(17).

PMID: 34502075 PMC: 8431139. DOI: 10.3390/ijms22179167.


DNA Methylation, Mechanisms of Inactivation and Therapeutic Perspectives for Fragile X Syndrome.

Nobile V, Pucci C, Chiurazzi P, Neri G, Tabolacci E Biomolecules. 2021; 11(2).

PMID: 33669384 PMC: 7920310. DOI: 10.3390/biom11020296.